NCT02343016 NIRS as a Continuous Noninvasive Monitoring System of Liver/Kidney Graft Perfusion Status TERMINATED Phase N/A
NCT02194582 Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02134314 C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI Status COMPLETED Phase PHASE1/PHASE2
NCT01982903 Prospective Study of Urinary Markers of Fibrosis in Kidney Transplants Status UNKNOWN Phase N/A
NCT01974999 A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 Study Status COMPLETED Phase N/A
NCT01894906 Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients Status COMPLETED Phase PHASE1/PHASE2
NCT01860183 Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis Status COMPLETED Phase PHASE4
NCT01756508 Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury Status COMPLETED Phase PHASE2
NCT01725113 Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol Status TERMINATED Phase PHASE4
NCT01595984 Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME) Status UNKNOWN Phase PHASE3
NCT01564966 Cardiovascular-Renal Consequences of Reducing Renal Mass After Living Kidney Donation Status COMPLETED Phase N/A
NCT01554982 A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis Status COMPLETED Phase PHASE3
NCT01536548 Indicating Direction and Angle for Cannulating of AV-fistula in Hemodialysis Patients Status COMPLETED Phase NA
NCT01471041 Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae Status COMPLETED Phase PHASE2/PHASE3
NCT01447368 Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients Status COMPLETED Phase PHASE4
NCT01446484 Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection Status UNKNOWN Phase PHASE1/PHASE2